We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals

390 hedge funds and large institutions have $15.4B invested in Alnylam Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 149 increasing their positions, 116 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $83.9M | Put options by funds: $54.4M

53% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 36

28% more repeat investments, than reductions

Existing positions increased: 149 | Existing positions reduced: 116

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

10% more capital invested

Capital invested by funds: $14B → $15.4B (+$1.39B)

4% more funds holding

Funds holding: 374390 (+16)

0.55% more ownership

Funds ownership: 92.99%93.54% (+0.55%)

Holders
390
Holders Change
+16
Holders Change %
+4.28%
% of All Funds
6.85%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
55
Increased
149
Reduced
116
Closed
36
Calls
$83.9M
Puts
$54.4M
Net Calls
+$29.5M
Net Calls Change
+$19.9M
Name Holding Trade Value Shares
Change
Change in
Stake
HNB
351
Huntington National Bank
Ohio
$11K +$12.2K +81 New
MAM
352
Meeder Asset Management
Ohio
$10K -$2.26K -15 -18%
CTC
353
Central Trust Company
Missouri
$9K
EARNEST Partners
354
EARNEST Partners
Georgia
$9K
PFSC
355
Peoples Financial Services Corp
Pennsylvania
$7K
SL
356
Savior LLC
Massachusetts
$7K
SJIM
357
St. Johns Investment Management
Florida
$7K
VFA
358
Valeo Financial Advisors
Indiana
$6K -$301 -2 -4%
CFGS
359
Concourse Financial Group Securities
Alabama
$6K +$6.47K +43 New
CWP
360
Concord Wealth Partners
Virginia
$6K +$6.62K +44 New
EFSCE
361
Enterprise Financial Services Corp (EFSC)
Missouri
$5K
WT
362
Whittier Trust
California
$5K
IA
363
IFP Advisors
Florida
$5K +$3.46K +23 +192%
BWL
364
Bogart Wealth LLC
Virginia
$5K +$5.42K +36 New
TPCW
365
TD Private Client Wealth
New York
$4.66K
Nisa Investment Advisors
366
Nisa Investment Advisors
Missouri
$4.38K +$2.36M +15,700 +103%
PWMG
367
Prestige Wealth Management Group
New Jersey
$4K
TFO
368
Tarbox Family Office
California
$4K
CFA
369
Carroll Financial Associates
North Carolina
$4K +$5.12K +34 New
FHA
370
First Horizon Advisors
Tennessee
$3K
PFBT
371
Parkside Financial Bank & Trust
Missouri
$3K
EW
372
Evoke Wealth
California
$3K +$2.71K +18 New
TWA
373
TCI Wealth Advisors
Arizona
$3K +$2.86K +19 +380%
MWP
374
Meridian Wealth Partners
Pennsylvania
$3K +$3.31K +22 New
AIC
375
Ameritas Investment Company
Nebraska
$2.54K +$2.71K +18 New

ALNY Hedge Fund Activity: Q1 2021 in Review

390 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2021, worth a combined $15.4B — up 9.9% from $14B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new ALNY positions and 36 closed out — a net gain of 19 holders — while 149 added to existing stakes and 116 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $219M. The largest seller was Wellington Management Group, cutting an estimated $137M.

  • 390 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2021, up from 374 in Q4 2020.
  • Funds reported $15.4B of Alnylam Pharmaceuticals stock for Q1 2021, up 9.9% quarter-over-quarter.
  • 55 funds opened new Alnylam Pharmaceuticals positions in Q1 2021 and 36 closed out, a net change of +19 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2021 was Fidelity Investments, an estimated $219M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2021 was Wellington Management Group, an estimated $137M sold.

Based on aggregated 13F filings for Q1 2021.